TABLE OF CONTENTS
Volume 27, Issue 36 (21 August 2008)
Original Articles
Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells
H Makkonen, T Jääskeläinen, T Pitkänen-Arsiola, M Rytinki, K K Waltering, M Mättö, T Visakorpi and J J Palvimo
Oncogene 27: 4865-4876; advance online publication, May 12, 2008; doi:10.1038/onc.2008.125
Protein cysteine sulfinic acid reductase (sulfiredoxin) as a regulator of cell proliferation and drug response
K Lei, D M Townsend and K D Tew
Oncogene 27: 4877-4887; advance online publication, May 5, 2008; doi:10.1038/onc.2008.132
Truncation mutations abolish chromatin-associated activities of adenomatous polyposis coli
A P Kouzmenko, K Takeyama, Y Kawasaki, T Akiyama and S Kato
Oncogene 27: 4888-4899; advance online publication, May 5, 2008; doi:10.1038/onc.2008.127
P21-activated kinase is required for mitotic progression and regulates Plk1
B Maroto, M B Ye, K von Lohneysen, A Schnelzer and U G Knaus
Oncogene 27: 4900-4908; advance online publication, April 21, 2008; doi:10.1038/onc.2008.131
Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators
G Roué, V Pichereau, H Lincet, D Colomer and B Sola
Oncogene 27: 4909-4920; advance online publication, April 28, 2008; doi:10.1038/onc.2008.126
Oncogenic Ras upregulates NADPH oxidase 1 gene expression through MEK-ERK-dependent phosphorylation of GATA-6
Y Adachi, Y Shibai, J Mitsushita, W H Shang, K Hirose and T Kamata
Oncogene 27: 4921-4932; advance online publication, May 5, 2008; doi:10.1038/onc.2008.133
Identification and characterization of novel AML1-ETO fusion transcripts in pediatric t(8;21) acute myeloid leukemia: a report from the Children's Oncology Group
K M LaFiura, H Edwards, J W Taub, L H Matherly, J A Fontana, A N Mohamed, Y Ravindranath and Y Ge
Oncogene 27: 4933-4942; advance online publication, May 12, 2008; doi:10.1038/onc.2008.134
Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1 -/- mice
N Leung, C Turbide, B Balachandra, V Marcus and N Beauchemin
Oncogene 27: 4943-4953; advance online publication, May 5, 2008; doi:10.1038/onc.2008.136
Transgenic expression of E2F3a causes DNA damage leading to ATM-dependent apoptosis
Q X Paulson, R V Pusapati, S Hong, R L Weaks, C J Conti and D G Johnson
Oncogene 27: 4954-4961; advance online publication, May 12, 2008; doi:10.1038/onc.2008.138
Short Communications
An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions
C-H Nam, M N Lobato, A Appert, L F Drynan, T Tanaka and T H Rabbitts
Oncogene 27: 4962-4968; advance online publication, April 28, 2008; doi:10.1038/onc.2008.130
Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomas
A Sánchez, F Setién, N Martinez, J L Oliva, M Herranz, M-F Fraga, M Alaminos, M Esteller and J M Rojas
Oncogene 27: 4969-4972; advance online publication, April 21, 2008; doi:10.1038/onc.2008.129
